A. Shenvi

发表

The Mechanism of γ-Secretase

B. Greenberg, Xiaodong Liu, D. Aharony, 2003, Journal of Biological Chemistry.

Preclinical Pharmacology and Pharmacokinetics of AZD3783, a Selective 5-Hydroxytryptamine 1B Receptor Antagonist

Diansong Zhou, P. Bernstein, M. E. Pierson, 2011, Journal of Pharmacology and Experimental Therapeutics.

Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes.

W. Bachovchin, S. Farr-Jones, C. Kettner, 1988, Biochemistry.

A new peptide boronic acid inhibitor of elastase-induced lung injury in hamsters.

N. Soskel, J. Punt, C. Kettner, 1986, The American review of respiratory disease.

Nonadrenergic, noncholinergic contractile responses of the guinea pig hilar bronchus involve the preferential activation of tachykinin neurokinin2 receptors.

L. Renzetti, A. Shenvi, C. Buckner, 1992, The Journal of pharmacology and experimental therapeutics.

Discovery of novel, orally active dual NK1/NK2 antagonists.

W. Rumsey, P. Bernstein, J. Albert, 2001, Bioorganic & medicinal chemistry letters.

4-Alkylpiperidines related to SR-48968: potent antagonists of the neurokinin-2 (NK2) receptor.

D. Aharony, R. Mauger, R. Jacobs, 1998, Bioorganic & medicinal chemistry letters.

Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.

W. Rumsey, B. Undem, P. Bernstein, 2001, The Journal of pharmacology and experimental therapeutics.

Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.

C. Kettner, A. Shenvi, 1984, The Journal of biological chemistry.

Design, synthesis, and SAR of tachykinin antagonists: modulation of balance in NK(1)/NK(2) receptor antagonist activity.

Daniel C. Hill, W. Rumsey, P. Bernstein, 2002, Journal of medicinal chemistry.

An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidases.

M. Hussain, C. Koval, A. Shenvi, 1990, Life sciences.

alpha-Aminoboronic acid derivatives: effective inhibitors of aminopeptidases.

A B Shenvi, A. Shenvi, 1986, Biochemistry.

The Use of α-Aminoboronic Acid Derivatives to Stabilize Peptide Drugs During Their Intranasal Absorption

M. Hussain, E. Shefter, S. Rowe, 1989, Pharmaceutical Research.

Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.

M. Hussain, C. Koval, A. Shenvi, 1990, Journal of pharmaceutical sciences.

Convenient synthesis of 3-methyl-2,3,4,4a.alpha.,5,6,7,7a.alpha.-octahydro-1H-benzofuro[3,2-e]isoquinoline

E. Ciganek, A. Shenvi, 1984 .

BIOMIMETIC POLYENE CYCLIZATIONS. PARTICIPATION OF THE PHENYLACETYLENIC GROUP AS A TERMINATOR AND THE FORMATION OF C/D CIS STEROIDAL PRODUCTS

W. S. Johnson, A. Shenvi, L. R. Hughes, 1979 .

An approach to taxodione involving biomimetic polyene cyclization methodology

W. S. Johnson, A. Shenvi, S. Boots, 1982 .

Interaction of peptide boronic acids with elastase: Circular dichroism studies

A. Fink, C. Kettner, A. Shenvi, 1988, Proteins.

Serine protease mechanism: structure of an inhibitory complex of alpha-lytic protease and a tightly bound peptide boronic acid.

D. Agard, R. Bone, C. Kettner, 1987, Biochemistry.

Recent advances in neurokinin receptor antagonists.

A. Shenvi, 2003, Current topics in medicinal chemistry.

Preparation of a fluorinated shikimic acid

F. Weigert, A. Shenvi, 1994 .

The Mechanism of -Secretase MULTIPLE INHIBITOR BINDING SITES FOR TRANSITION STATE ANALOGS AND SMALL MOLECULE INHIBITORS*

B. Greenberg, D. Aharony, G. Tian, 2003 .

Preclinical Pharmacology and Pharmacokinetics of AZD3783, a Selective 5-Hydroxytryptamine 1B Receptor Antagonist

Diansong Zhou, P. Bernstein, M. E. Pierson, 2011, Journal of Pharmacology and Experimental Therapeutics.